Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Elzovantinib |
Trade Name | |
Synonyms | TPX0022|TPX 0022|TPX-0022 |
Drug Descriptions |
Elzovantinib inhibits Met, Csf1r, and Src, which may lead to growth inhibition in tumor cells (PMID: 38564707, NCI Drug Dictionary). |
DrugClasses | CSF1R Inhibitor 28 MET Inhibitor 59 SRC Inhibitor 31 |
CAS Registry Number | 2271119-26-5 |
NCIT ID | C162676 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Elzovantinib | Elzovantinib | 0 | 1 |
Elzovantinib + Osimertinib | Elzovantinib Osimertinib | 0 | 0 |